the 6 W’s: Who, what, where, when, why and what of it

Stocks took-off in a jet propelled run last week … Euro news will determine if the plane continues to climb or if market passengers should prepare for a hard landing. According to technical GPS, the direction for higher prices is queued up.  in the past year, the NASDAQ has had 4 bullish MACD crossovers when the indicator is below zero … every single time, the index moved significantly higher in a hurry.

 I still don’t see the markets’ momentum affecting (with any drama/momentum) the RegMed universe …  as  residiual affects have not yet planted … but, my bell weathers are blooming (under winter sunlight); Athersys (ATHX) is responding with a $0.54<+32.53%> increase to $2.20; while NeoStem (AMEX: NBS) is starting to blossom UP $0.045 <+8.20%> to $0.595, Osiris (OSIR) is UP +$0.20 <+4.120> to $4.96, Cytori (CYTX) sloggs-on UP $0.02 <+0.76%> to $2.66 and Aastrom is UP $0.05 <+2.22%> to $2.17 (most, flat-lined for these turbulent times) while others continue to flat-line UP incrementally  $0.02 – $0.08.  

The key to measurement of true universe momentum will be the pricing movement beyond the $1.00 (NASDAQ/AMEX) mark for … a few below the minimum pricing to stay listed into the new year … I DO BELIEVE  … it will happen … KOOL and NBS … into January!

Mid-Day: the NASDAQ is UP +46.80 (+1.78%) to 2,673.73. the Dow is UP +143.19 (+1.19%) to 12,162.61.

Mid-Day Movers: Aastrom (ASTM), Athersys (ATHX), BioTime (AMEX: BTX), Cytori (CYTX),Dendreon (DNDN), ImmunoCellular (OTC BB: IMUC), NeoStem (AMEX: NBS), Osiris (OSIR), Pluristem (PSTI), StemCells (STEM), Tengion (TNGN) and ThermoGenesis (KOOL)

What’s new in the regenerative medicine/stem cell market:

Drug eases GVHD symptoms in patients who had stem cell transplant: Daily, low-dose injections of interleukin-2 eased symptoms of graft-versus-host disease, or GVHD, in cancer patients who underwent allogeneic hematopoietic stem cell transplantation, according to a study published in the new England Journal of Medicine. Of 23 patients given the drug for 8 weeks, 12 showed improvement, according to the study.

Researchers develop iPS cells from Pompe disease cells:  Taiwanese researchers have developed induced pluripotent stem cells, or iPS cells, from the skin cells of patients with Pompe disease. the researchers tested drugs on the iPS cells and were able to pinpoint marker genes whose expression correlates with the effect of drug treatment. the findings could aid in early diagnosis, drug testing and disease marker identification.

Researchers use nanofiber scaffold to grow trachea for transplant:  Swedish researchers used a nanofiber scaffold from Nanofiber Solutions to grow a synthetic trachea for transplant. the researchers used the patient’s own stem cells to grow the organ in the lab. the procedure is the world’s second successful synthetic trachea transplant, according to Harvard Bioscience.

Court says bone marrow donors can be compensated: The 9th U.S. Circuit Court of Appeals has ruled that bone marrow donors can be compensated for their donations because bone marrow cells, which are obtained from a donor’s blood, can be considered as blood parts and not organ parts. Because of the ruling, bone marrow donations can now be exempted from the ban set forth by the 1984 National Organ Transplant Act, which prohibits compensation for donated organs and donated organ parts. the move is expected to spur a significant increase in the number of bone marrow donors in theU.S.

Researchers grow partial pituitary gland using stem cells: Japanese researchers used embryonic stem cells to grow partial pituitary glands, then transplanted the tissue in the kidneys of mice without pituitary glands. the transplanted tissue returned hormone levels to normal, according to the study published in Nature. the initiative is part of a worldwide effort to grow complete organs in a lab setting using stem cells.

Researchers attain functional muscle regeneration in mice:  Researchers from the Worcester Polytechnic Institute and CellThera have successfully regenerated functional muscle tissue in mice by growing stem-cell-like human muscle cells on biopolymer microthreads, which were found to help accelerate the process of tissue generation. Findings suggest that “fibrin microthreads alone have tremendous potential for reducing fibrosis and remodeling large muscle injuries,”

Register here to be notified of future Scimitar Equity articles.

Filed under: Lung Cancer

One of a misfortune cancer census interpretation anywhere in a universe is lung cancer Lung Cancer Stages And Symptoms. Published 5-year presence for patients with lung cancer varies from 5% to 16% internationally. one of a reasons which a cancer presence rates talk about so during large is a actuality which a statistical report is not regularly in a open domain, as well as any particular investigate collects as well as interprets a interpretation otherwise according to a epitome of a study. in alternative disproportion any cancer statistic is as singular as we are.

Data from a US indicates a 5-year presence rate of up to 16% nonetheless this figure cannot be relied upon since it excludes seventy 5 percent of a population, so as a statistic it does not request to a race as a whole. to have a current some-more aged of mankind rates for cancer presence rates is no opposite from creation current statistical justification in any alternative disease, a interpretation has to have been picked up as well as carefully thought about in a same way. ( Respiratory Medicine, Volume 100, Issue 9, Pages 1642-1646 C. Butler, K. Darragh, G. Currie, W. Anderson, Respiratory Medicine, Volume 100, Issue 9, Pages 1642-1646). Being fearful by census interpretation or even worse desiring census interpretation can start how we tarry or not your cancer.

Changing a Face of Cancer Survival Statistics

Statistics come down to risks during a finish of a day as well as your risk of removing cancer. in a United States a census interpretation for lung cancer exhibit which it kills some-more people than those which die from breast cancer, prostate cancer, colon cancer as well as cervical cancer combined. However which is due to a actuality which there is drawn out screening over a sure age for prostrate, breast as well as cervical cancer.

Lung Cancer Staging Prognosis

The New England Journal of Medicine of Oct 26, 2006 reported which eighty percent of deaths from lung cancer were potentially avoidable. Spiral computed tomography (CT) scanning has a intensity to acknowledge it during a early theatre 1 stage, during this theatre it is a curable cancer. the reason which a mankind rates have been so dour is a actuality which by a time many people comprehend which they have this cancer, it is as well distant modernized to do anything about it.

The primary investigate was carried out during a New York Weill Cornell Medical Center during 1993 as well as has subsequently stretched in to an general investigate of 38 institutions in 7 countries as well as turn well well well known as a International Early Lung Cancer Action Project (I-ELCAP).

Surgery is in effect in restorative this cancer is theatre 1, after it is as well modernized to have most disproportion as well as a reason which a cancer rate presence census interpretation have been so gloomy is a actuality which it is frequency rescued during theatre 1.

Later studies from 1993 to 2005 in a United States, Europe, Israel, China, as well as Japan screened 31,567 asymptomatic persons during tall risk followed by repeat screenings in 27,456 of these individuals. 484 people were diagnosed with lung cancer, as well as 412 or 85% of these were Stage I. of a 412 patients with theatre I, 302 underwent surgical solutions inside of 4 weeks as well as inside of this group, a presence rate was 92%.

The estimated 10 year presence rate for a 484 participants with lung cancer was over 80 percent which is a top commission for presence ever accessible in a cancer study. in contrariety a statistical cancer 5 year presence rates for theatre IV can be as low as 5%. Some inaugurated not to embrace treatment as well as all were passed inside of 5 years. All a participants were during risk of lung cancer as they were all comparison than forty as well as possibly they smoked or had smoked or they were unprotected to well well well known carcinogenic substances such as asbestos, uranium, radon or beryllium, uranium or radon, or they had occupations which unprotected them to pacifist smoking.

As with anything else a price efficacy of a screening has to be totalled opposite a price of treatment. it costs twice as most to provide lung cancer in a late stages than it does for theatre 1 treatment. the assign for a low sip CT screening indicate is in between 0 – 0. New record has done a screening some-more in effect since when CT was latest it was usually able of agreeable thirty images right away over 600 have been possible.

To a sure border there is insurgency to scanning for lung cancer since mostly it is not regarded as a mildew though as a rebuke or retribution. Also there is small accord as to what constitutes a tall risk population, since nonetheless it has been well well well known for a century which smoking contributes to cancer, by no equates to all smokers rise lung cancer. However improved genetic pointers will be accessible in a destiny as well as which will have it simpler to envision just those during risk as well as which will have a probability of screening some-more likely.

lung cancer treatment breakthroughs Click here

lung cancer most appropriate treatment Click here

Article from articlesbase.com

Incoming search terms for the article:

• long term smoking can lead to lung disease such as which can lead to lung cancer

Sponsored Links Advertisements

Tags: Cancer, Lung, Stages, symptoms